We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

MDRNA, Inc. Announces Patent Allowance Covering Intranasal Formulations for Y2-Receptor Agonists

Allowance broadens portfolio for the treatment of obesity and related diseases.
News

Sequence is Scaffold to Study Sleeping Sickness

Study probes Trypanosoma parasite genome for cause of human infectivity.
News

Medical Research Council Technology and Pharmidex Announce Drug Discovery Collaboration

Pharmidex to provide all in vivo ADME/PK drug discovery support to the MRCT in 2010.
News

PROjEN and Axion Form Strategic Alliance

Alliance aimed to develop business opportunities in the biofuels, advanced thermal waste processing, specialty chemicals and mineral processing sectors.
News

Rhenovia Wins Contract to Lead $3.75M Biosimulation Project

Collaborative project extends Rhenovia’s CNS biosimulation platform to study of epilepsy.
News

Additional Genes Associated with Age-Related Macular Degeneration Identified

A large genetic study of AMD has identified three new genes associated with this blinding eye disease-two involved in the cholesterol pathway.
News

BioFocus Launches Four Compound Libraries Targeting Kinases and Protein-Protein Interactions

These new libraries contain novel, drug-like compounds that specifically target kinases and protein-protein interactions.
News

MDRNA, Inc. Announces Patent Allowance Covering Intranasal Formulations for Y2-Receptor Agonists

Allowance broadens portfolio for the treatment of obesity and related diseases.
News

Polyphor Ltd and Axxam SpA Announce Ion Channel Collaboration

Both the companies will work together to discover and develop drug candidates for selected therapeutic areas.
News

RXi and miRagen Announce Formation of Research Collaboration in the Field of microRNAs

The collaboration will evaluate the potential utility of RXi’s rxRNA™ technology against specific miRNA targets of interest to mirage.
Advertisement